Lingvay I, Cheng AY, Levine JA, Gomez-Valderas E, et al. Achievement of glycemic targets with weight loss and without hypoglycemia in type 2 diabetes with once-weekly GIP and GLP-1 receptor agonist tirzepatide: a post-hoc analysis of the SURPASS-1 to -5 studies. Diabetes Obes Metab 2022 Dec 13. doi: 10.1111/dom.14943.
PMID: 36514843